A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
The main endpoint, seroconversion, characterized by a SARS-CoV-2-binding Antibody concentration exceeding 10 BAU/mL on day 28 post-second vaccination, is assessed centrally via a fluorescent bead-based technique
*ALA and ALC support the bodys maintenance of cell function, helping to keep cells healthy and fighting the effects of aging
Safety Comparison Table# Research Evidence Comparison# Amycretin Research# Amycretin has early but impressive data: Phase 1 (SC): Published in The Lancet (2025)
The intracellular Km for carnitine, which is also important for understanding the mechanism of carnitine traffic has been measured only in proteoliposomes, an experimental system which gives access to the internal face of a transporter (Scalise et al., 2013)
Not all commercially available preparations of a given antibody will react the same way between different laboratories and between different species